Kare Schultz earned $107m during Teva tenure Finances April 20, 2023 [ad_1] Former Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Kåre Schultz earned $107 million throughout his time…
A Black YC alum explains how he raised $107M • TechCrunch Startups February 13, 2023 [ad_1] Nathan Beckord Contributor Extra posts by this contributor Chilly outreach with a heat contact: Right here’s the quick pitch…
